Carl Bjartmar - Concepedia

Author

Carl Bjartmar

Cleveland Clinic

Also Known As

Bjartmar, C., C BJARTMAR, C Bjartmar, C. Bjartmar, Carl Bjartmar

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Cleveland Clinic Linköping University Cleveland Clinic Lerner College of Medicine University of Kansas Medical Center Institute of Psychiatry and Neurology

About

Carl Bjartmar is an author at Cleveland Clinic specializing in medicine, neuroscience, and neuroanatomy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.3K
2	Cell Biology	3	3	58
3	Cellular Physiology	3	3	58
4	Health Sciences	2	2	55
5	Social Sciences	2	2	35

Carl Bjartmar

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Neurological disability correlates with spinal cord axonal loss and reducedN-acetyl aspartate in chronic multiple sclerosis patients Carl Bjartmar, Grahame J. Kidd, Sverre M�rk, Annals of Neurology Neurological DisorderNeurological ProgressNeurological FunctioningAxonal DegenerationNeurology	2000	564
Axon Loss in the Spinal Cord Determines Permanent Neurological Disability in an Animal Model of Multiple Sclerosis Jerome R. Wujek, Carl Bjartmar, Edward Richer, Journal of Neuropathology & Experimental Neurology Neurological DisorderImmunologyInflammatory Demyelinating DiseaseAxon LossNeurological Injury	2002	300
Axonal loss in normal-appearing white matter in a patient with acute MS Carl Bjartmar, R. Philip Kinkel, Grahame J. Kidd, Neurology	2001	283
N‐acetylaspartate is an axon‐specific marker of mature white matter in vivo: A biochemical and immunohistochemical study on the rat optic nerve Carl Bjartmar, Jan Battistuta, Nobuo Terada, Annals of Neurology	2001	169
Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study Karl Heinz Weiss, Frederick K. Askari, Anna Członkowska, The Lancet. Gastroenterology & hepatology Translational MedicinePharmacologyBis-choline TetrathiomolybdateNeurologyPhase 2	2017	162
Axonal degeneration and progressive neurologic disability in multiple sclerosis Carl Bjartmar, Bruce D. Trapp Neurotoxicity Research NeurorehabilitationNeurological DisorderAxonal DegenerationNeuroscienceNeurology	2003	133
Morphological heterogeneity of rat oligodendrocytes: Oligodendrocytes: Electron microscopic studies on serial sections Carl Bjartmar, C. Hildebrand, Kristina Loinder Glia	1994	96
The tetraspanin protein, CD9, is expressed by progenitor cells committed to oligodendrogenesis and is linked to β1 integrin, CD81, and Tspan‐2 Nobuo Terada, Karen L. Baracskay, Shona Melrose, Glia	2002	83
Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study Ans van der Ploeg, Pierre G. Carlier, Robert-Yves Carlier, Molecular Genetics and Metabolism	2016	72
Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease Laura E. Case, Carl Bjartmar, Claire Morgan, Neuromuscular Disorders Pompe DiseaseTranslational MedicineAutoimmune DiseaseTherapeutic EfficacyMedicine	2014	58

Page 1